Pacira BioSciences' Short-term Investments fell 5249.1% to $98.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $98.7 million, marking a year-over-year decrease of 5249.1%. This contributed to the annual value of $207.8 million for FY2024, which is 6589.72% up from last year.
According to the latest figures from Q3 2025, Pacira BioSciences' Short-term Investments is $98.7 million, which was down 5249.1% from $145.4 million recorded in Q2 2025.
Pacira BioSciences' 5-year Short-term Investments high stood at $559.8 million for Q3 2021, and its period low was $70.8 million during Q4 2021.
Its 5-year average for Short-term Investments is $222.2 million, with a median of $184.5 million in 2022.
Per our database at Business Quant, Pacira BioSciences' Short-term Investments crashed by 8320.37% in 2021 and then surged by 16049.61% in 2022.
Over the past 5 years, Pacira BioSciences' Short-term Investments (Quarter) stood at $70.8 million in 2021, then surged by 160.5% to $184.5 million in 2022, then plummeted by 32.1% to $125.3 million in 2023, then surged by 65.9% to $207.8 million in 2024, then plummeted by 52.49% to $98.7 million in 2025.
Its last three reported values are $98.7 million in Q3 2025, $145.4 million for Q2 2025, and $210.0 million during Q1 2025.

Peer Comparison

Historic Data

Download Data 🔒

Date	Value